Published in Clin Infect Dis on July 01, 2010
Polypoid lesions at the anal canal: what do they hint? Intest Res (2017) 0.75
Human papillomavirus infection in anal intraepithelial lesions from HIV infected Cuban men. Infect Agent Cancer (2017) 0.75
The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA (2002) 15.59
Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis (2002) 2.22
Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis (2004) 2.21
Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol (1999) 2.13
HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr (2004) 1.64
Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis (2008) 1.55
High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis (2004) 1.20
Papillomavirus antigens in anorectal condyloma and carcinoma in homosexual men. JAMA (1987) 1.07
High prevalence of anal squamous intraepithelial lesions and squamous-cell carcinoma in men who have sex with men as seen in a surgical practice. Dis Colon Rectum (2001) 1.05
Anal condyloma: a comparison between HIV positive and negative patients. Am Surg (2004) 0.99
Risk of dysplasia in anal condyloma. Surgery (1995) 0.94
The frequency of high-grade intraepithelial neoplasia in anal/perianal warts is higher than previously recognized. Int J STD AIDS (2007) 0.89
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med (2010) 36.78
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med (2005) 4.83
HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. Am J Hematol (2008) 3.21
Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet (2004) 2.47
Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol (2002) 2.10
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood (2009) 2.07
HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients. Clin Infect Dis (2006) 1.88
The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol (2006) 1.69
AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist (2005) 1.69
The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin Infect Dis (2012) 1.62
Kaposi sarcoma in unusual locations. BMC Cancer (2008) 1.60
Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study. BJU Int (2008) 1.55
Human immunodeficiency virus-associated hemophagocytosis with iron-deficiency anemia and massive splenomegaly. Clin Infect Dis (2003) 1.54
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. PLoS Pathog (2009) 1.53
Time for oncologists to opt in for routine opt-out HIV testing? JAMA (2010) 1.53
Primary esophageal carcinoma in the era of highly active antiretroviral therapy. Arch Intern Med (2010) 1.52
Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res (2005) 1.48
Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation. J Infect Dis (2009) 1.46
Thrombotic complications in patients infected with HIV in the era of highly active antiretroviral therapy: a case series. Clin Infect Dis (2004) 1.44
Spectrum of human papillomavirus-related dysplasia and carcinoma of the anus in HIV-infected patients. AIDS Read (2005) 1.43
HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis (2008) 1.42
The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol (2002) 1.41
Images in HIV/AIDS. Sweet syndrome and syphilis in an HIV-infected person. AIDS Read (2008) 1.39
HIV infection masquerading as monoclonal gammopathy of undetermined significance. N Engl J Med (2003) 1.39
HHV8 is not limited to Kaposi's sarcoma. Mod Pathol (2005) 1.38
Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol (2004) 1.29
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study. Br J Haematol (2015) 1.29
Management of AIDS-related Kaposi's sarcoma. Lancet Oncol (2007) 1.26
A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas. Clin Cancer Res (2012) 1.21
High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis (2004) 1.20
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol (2002) 1.16
Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study. Cancer (2008) 1.10
Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood (2009) 1.09
Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer (2010) 1.08
Breast cancer in HIV positive women: a report of four cases and review of the literature. Cancer Invest (2003) 1.08
Human immunodeficiency virus-associated adenocarcinoma of the colon: clinicopathologic findings and outcome. Clin Colorectal Cancer (2009) 1.08
HIV-associated multicentric Castleman's disease. Am J Hematol (2008) 1.07
Effects of chemotherapy in AIDS-associated non-Hodgkin's lymphoma on Kaposi's sarcoma herpesvirus DNA in blood. J Clin Oncol (2009) 1.06
Kaposi sarcoma of the musculoskeletal system: a review of 66 patients. Cancer (2007) 1.04
Human Immunodeficiency Virus-associated anaplastic large cell lymphoma. Leuk Lymphoma (2010) 1.03
Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr (2011) 1.02
Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study. J Invest Dermatol (2008) 1.01
A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer. Clin Cancer Res (2006) 0.99
HIV-associated bladder cancer: a case series evaluating difficulties in diagnosis and management. BMC Urol (2009) 0.99
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial. Gynecol Oncol (2005) 0.99
Evolving spectrum and incidence of non-AIDS-defining malignancies. Curr Opin HIV AIDS (2009) 0.99
Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient. J Natl Med Assoc (2006) 0.98
Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr (2008) 0.98
AIDS-related Kaposi's sarcoma of the gastrointestinal tract. J Clin Oncol (2010) 0.97
Phase II trial of imatinib in AIDS-associated Kaposi's sarcoma: AIDS Malignancy Consortium Protocol 042. J Clin Oncol (2013) 0.95
Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol (2012) 0.94
Reasons for a deficit of breast cancer among HIV-infected patients. J Clin Oncol (2004) 0.94
AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART. AIDS Read (2004) 0.93
New approaches in the treatment of HIV/AIDS - focus on maraviroc and other CCR5 antagonists. Ther Clin Risk Manag (2008) 0.91
Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites--the unknown role of underlying HIV infection. J Natl Med Assoc (2006) 0.91
Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis (2009) 0.91
Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008). Cancer Immunol Immunother (2015) 0.89
C-Kit (CD117) expression in AIDS-related, classic, and African endemic Kaposi sarcoma. Appl Immunohistochem Mol Morphol (2005) 0.88
Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic Acid. Clin Infect Dis (2009) 0.87
Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. J Acquir Immune Defic Syndr (2012) 0.87
Morphologic and immunophenotypic evidence of in-situ Kaposi's sarcoma. BMC Clin Pathol (2006) 0.86
Targeted therapy for Kaposi sarcoma. BioDrugs (2009) 0.86
Matrix metalloproteinases in the progression and regression of Kaposi's sarcoma. J Cutan Pathol (2006) 0.86
Pathology of rituximab-induced Kaposi sarcoma flare. BMC Clin Pathol (2008) 0.85
Pathology of Kaposi's sarcoma. J HIV Ther (2009) 0.85
Breast enlargement in 13 men who were seropositive for human immunodeficiency virus. Clin Infect Dis (2002) 0.85
Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook. Curr Opin Oncol (2009) 0.85
November 2002: a 72-year-old woman with a pineal gland mass. Brain Pathol (2003) 0.84
Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Cutan Pathol (2004) 0.84
Unusual sites of Hodgkin's lymphoma: CASE 1. HIV-associated Hodgkin's lymphoma of the stomach. J Clin Oncol (2004) 0.84
Antimicrobial and non-antimicrobial tetracyclines in human cancer trials. Pharmacol Res (2010) 0.83
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors. Clin Cancer Res (2007) 0.83
Signal transduction targets in Kaposi's sarcoma. Curr Opin Oncol (2006) 0.83
Editorial comment: multiple myeloma and HIV infection--causal or casual coincidence? AIDS Read (2003) 0.83
Primary Kaposi sarcoma of the subcutaneous tissue. World J Surg Oncol (2008) 0.83
Fine needle aspiration of salivary gland masses in HIV-infected patients. Diagn Cytopathol (2011) 0.83
Kaposi's sarcoma and pregnancy. Am J Perinatol (2005) 0.83
Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma. AIDS (2002) 0.82
Editorial comment: plasmablastic lymphoma--a diagnostic and therapeutic puzzle. AIDS Read (2007) 0.81
Acute myeloid leukemia in patients infected with HIV-1. AIDS (2002) 0.81
Monoclonal antibody hNM01 in HIV-infected patients: a phase I study. J Clin Virol (2004) 0.80
Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi's sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial. Cancer Chemother Pharmacol (2011) 0.80
The inflammatory component of Kaposi sarcoma. Exp Mol Pathol (2009) 0.80
Advances in the pathobiology and treatment of Kaposi sarcoma. Curr Opin Oncol (2004) 0.80
Fine needle aspiration of breast masses in HIV-infected patients: results from a large series. Cancer Cytopathol (2010) 0.80
Peripheral T-cell lymphomas in HIV-infected individuals: a comprehensive review. J HIV Ther (2009) 0.80
Protein electrophoresis and immunoglobulin analysis in HIV-infected patients. Am J Clin Pathol (2007) 0.80
Nuclear factor kappa B pathway associated biomarkers in AIDS defining malignancies. Int J Cancer (2011) 0.80
Kaposi Sarcoma Pathogenesis: A Triad of Viral Infection, Oncogenesis and Chronic Inflammation. Transl Biomed (2010) 0.79
A 57-year-old HIV-positive man with persistent fever, weight loss, and pancytopenia. Am J Hematol (2009) 0.79
Pitfalls of diagnosis based on abnormal flow cytometry and [(18)F]fluorodeoxyglucose positron emission tomography. Clin Lymphoma Myeloma (2008) 0.79
Unusual Sites of Malignancies: CASE 3. AIDS-related Kaposi's sarcoma of the gastrointestinal tract. J Clin Oncol (2005) 0.79
Oral glucosamine supplements as a possible ocular hypertensive agent. JAMA Ophthalmol (2013) 0.78
HIV and the breast. AIDS Read (2005) 0.78